Definitely CANNOT work 2 brokers @ same time - PANL was another one on watch over @ $500 account & took my eyes off of it to check real broker and the damn thing went over $6 & is @ $6.35 so another scalp missed there while posting it jumped - $6.94 now i quit & will try again next week and another one gets halted lol
was all set to add CLEG & DCIX to other account to scalp & turns out they were done & 2 of my 3 picks there were pretty good ones with one being much better than the other. ZSAN didn't do much so will stay on watch & will aim to play over on $500 account next week & will also make sure that i don't separate my watch lists again
new pick: XIN: $5.90 - earnings just released - real estate dev. in China & US: Revenue In the third quarter of 2017, the Company's total revenue increased 8.6% to US$482.4 million from US$444.3 million in the third quarter of 2016 and decreased 1.2% from US$488.2 million in the second quarter of 2017. Revenue for the first nine months of 2017 totaled US$1.3 billion compared with US$1.1 billion for the same period last year. Gross Profit Gross profit for the third quarter of 2017 was US$108.8 million, or 22.6% of revenue, compared to a gross profit of US$105.0 million, or 23.6% of revenue, in the third quarter of 2016 and a gross profit of US$107.9 million, or 22.1% of revenue, in the second quarter of 2017. Net Income Net income for the third quarter of 2017 was US$16.5 million compared to US$28.0 million for the third quarter of 2016 and US$20.8 million for the second quarter of 2017. Net margin was 3.4% compared to 6.3% in the third quarter of 2016 and 4.3% in the second quarter of 2017. Diluted earnings per ADS were US$0.22, compared to US$0.41 per ADS in the third quarter of 2016 and US$0.14 per ADS in the second quarter of 2017. The Net Income this quarter was negatively impacted by a one-time US$13.0 million loss on extinguishment of debt incurred upon the Company's debt redemption in July 2017.
XRF: $9.40 + 12% - earnings release: China Rapid Finance Limited is a consumer lending company - principally engaged in providing a consumer lending marketplace for lenders and borrowers in China with predictive selection technology (PST), automated decisioning technology (ADT), and non-credit data analytic and risk-based pricing capabilities (mini YRD): Third Quarter 2017 Financial Highlights Total gross billings on transaction and service fees[ grew by 125% year-over-year to $43.1 million, or 76% over the previous quarter. Gross billings from consumption loans facilitated grew by 1258% year-over-year, representing more than a 12 times year-over-year increase, to $29.8 million, or 126% over the previous quarter. Gross billings from lifestyle loans facilitated were down 21% year-over-year to $13.4 million but up 18% sequentially over last quarter. Consumption loans facilitated account for 69% of total gross billings and are rising rapidly. Net revenue increased by 62% year-over-year to $27.2 million (after netting off customer acquisition incentives of $13.9 million) from $16.8 million (after netting off customer acquisition incentives of $1.5 million) in the prior year period, and 79% over the previous quarter from $15.2 million (after netting off customer acquisition incentives of $8.1 million) in the previous quarter.
i'm not offering any advice, but i'd take the $$$ & run....it's been a real yo-yo - can probably buy back in 8's - but, remember i don't know anything - have a great weekend!
watchlist gainers: XNET: $13.09 + 39% / OCUL: $5.37 + 7% / I: $3.96 + 5% / JKS: $28.41 + 5% / FRTA: $8.54 + 4% favs for next week: WIX, BRKS, XRF, XIN, ALRM, GEYLF, BDRBF, AKAM, SIFY, YIN
is this an attempt @ being humble b/c we both know this is not true . Hope you have a good one too! PS - just so you know >> that was a very great $4 yoyo that i will defintley be keeping better track of!!!
on mon. -earnings for JD, JP, WUBA, CCCR, CYD, FENG, QD --- all china --- should be a wild ride! well, i blew it on JONE, so i'm officially humbled YRD earnings Tues. - it could go 50+ imo...also, keep an eye on JMEI & XRF;
lol that's a BIG one!!!! Definitely will not be repeating that mistake again and should have kept better track of picks i had set up to watch @ $500 Growth Test once i realized i couldn't do any pre market trading there.
couple pre watch & this is one >> CRVS oversold territory - Corvus Pharmaceuticals Announces Updated Clinical Data from Phase 1/1b Study of CPI-444 and Biomarker Data for Potential Use in Patient Selection https://ca.finance.yahoo.com/news/corvus-pharmaceuticals-announces-updated-clinical-224500291.html
XNET coming down nice @Neil Allen you still holding some SORL - broke $6 in pre & hit that high again & probably should have sold but didn't yet...
